Calcipharm PMD Solution for Injection
Calcipharm PMD Solution for Injection
Not authorised
- Glucose monohydrate
- Boric acid
- Calcium gluconate
- Magnesium hypophosphite hexahydrate
Product identification
Medicine name:
Calcipharm PMD Solution for Injection
Active substance:
- Glucose monohydrate
- Boric acid
- Calcium gluconate
- Magnesium hypophosphite hexahydrate
Target species:
-
Sheep
Route of administration:
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Glucose monohydrate200.00/milligram(s)1.00millilitre(s)
-
Boric acid34.00/milligram(s)1.00millilitre(s)
-
Calcium gluconate166.00/milligram(s)1.00millilitre(s)
-
Magnesium hypophosphite hexahydrate85.97/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Sheep
-
Meat and offal0day
-
Milk0day
-
-
-
Subcutaneous use
-
Sheep
-
Meat and offal0day
-
Milk0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA12
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- 400 ml Type III glass vial (amber) sealed with rubber (black) wad and aluminium screw cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chem-Pharm
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
Responsible authority:
- HPRA
Authorisation number:
- VPA10823/014/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024